Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Itaú Unibanco
ITUB
$92.9B
| $1.57M | ﹤0.01% |
364,858
-1,487,961
| -80% | -$6.31M |
|
2327
Chemed
CHE
$6.96B
| $1.56M | ﹤0.01% |
2,910
+967
| +50% | +$493K |
|
|
GDEN
2328
DELISTED
Golden Entertainment
GDEN
| $1.56M | ﹤0.01% |
35,930
+12,519
| +53% | +$506K |
|
2329
Triple Flag Precious Metals
TFPM
$6.21B
| $1.56M | ﹤0.01% |
104,424
+104,224
| +52,112% | +$1.42M |
|
2330
OFG Bancorp
OFG
$2.24B
| $1.56M | ﹤0.01% |
62,572
+8,328
| +15% | +$233K |
|
2331
Skillsoft
SKIL
$68.1M
| $1.56M | ﹤0.01% |
38,943
+15,639
| +67% | +$560K |
|
|
CGC
2332
Canopy Growth
CGC
$400M
| $1.55M | ﹤0.01% |
88,851
+52,980
| +148% | +$1.26M |
|
2333
Rayonier
RYN
$6.44B
| $1.55M | ﹤0.01% |
51,515
-3,346
| -6% | -$103K |
|
2334
Rhythm Pharmaceuticals
RYTM
$7.09B
| $1.55M | ﹤0.01% |
87,118
-95,481
| -52% | -$2.4M |
|
2335
Perrigo
PRGO
$1.44B
| $1.55M | ﹤0.01% |
43,324
-45,597
| -51% | -$1.65M |
|
|
NETC
2336
DELISTED
Nabors Energy Transition Corp.
NETC
| $1.55M | ﹤0.01% |
147,898
| – | – |
|
2337
First Busey Corp
BUSE
$2.59B
| $1.55M | ﹤0.01% |
76,278
+56,929
| +294% | +$1.33M |
|
2338
National Vision
EYE
$1.82B
| $1.55M | ﹤0.01% |
82,343
+17,975
| +28% | +$585K |
|
2339
Amphastar Pharmaceuticals
AMPH
$890M
| $1.55M | ﹤0.01% |
41,314
-21,616
| -34% | -$709K |
|
|
DOOR
2340
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.55M | ﹤0.01% |
17,055
+5,736
| +51% | +$505K |
|
2341
Zentalis Pharmaceuticals
ZNTL
$339M
| $1.55M | ﹤0.01% |
89,964
-37,910
| -30% | -$768K |
|
2342
Acadia Healthcare
ACHC
$2.9B
| $1.55M | ﹤0.01% |
21,410
+3,742
| +21% | +$292K |
|
2343
ABM Industries
ABM
$2.85B
| $1.55M | ﹤0.01% |
34,393
+2,349
| +7% | +$109K |
|
2344
Old Republic International
ORI
$10.4B
| $1.54M | ﹤0.01% |
61,792
+15,909
| +35% | +$400K |
|
2345
Douglas Emmett
DEI
$1.98B
| $1.54M | ﹤0.01% |
125,113
-32,500
| -21% | -$472K |
|
2346
Extreme Networks
EXTR
$4.1B
| $1.54M | ﹤0.01% |
80,609
+1,690
| +2% | +$31.2K |
|
2347
Liberty Energy
LBRT
$3.08B
| $1.53M | ﹤0.01% |
119,523
+42,518
| +55% | +$629K |
|
2348
CALL
RingCentral
RNG
$4.98B
| $1.53M | ﹤0.01% |
+49,900
| New | +$1.78M |
|
|
2349
PUT
RingCentral
RNG
$4.98B
| $1.53M | ﹤0.01% |
+49,900
| New | +$1.78M |
|
2350
Kulicke & Soffa
KLIC
$4.85B
| $1.53M | ﹤0.01% |
29,038
-493
| -2% | -$25.6K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.